These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1508337)

  • 1. Correction of apathic-abulic manifestations of the processual defect by cholinotropic preparations.
    Vovin RYa ; Fakturovich AYa ; Golenkov AV; Lukin VO
    Neurosci Behav Physiol; 1992; 22(3):241-5. PubMed ID: 1508337
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correction of apathetic-abulic manifestations of schizophrenia with cholinotropic drugs].
    Vovin RIa; Fakturovich AIa; Golenkov AV; Lukin VO
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(2):111-5. PubMed ID: 1647606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choline chloride in schizophrenia.
    Davis KL; Hollister LE; Berger PA
    Am J Psychiatry; 1979 Dec; 136(12):1581-4. PubMed ID: 41455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Etiology of apathic-abulic syndromes].
    Jacewicz-Kramarz H; Warnecka-Przybylska M
    Psychiatr Pol; 1982; 16(3):145-50. PubMed ID: 7178299
    [No Abstract]   [Full Text] [Related]  

  • 5. Learning and memory of chronic alcoholics influenced cholinotropic drugs.
    Krus D; Vojtĕchovký M; Rubes J
    Act Nerv Super (Praha); 1967 Nov; 9(4):420-1. PubMed ID: 4889078
    [No Abstract]   [Full Text] [Related]  

  • 6. Sleep onset REM periods in schizophrenic patients.
    Taylor SF; Tandon R; Shipley JE; Eiser AS; Goodson J
    Biol Psychiatry; 1991 Jul; 30(2):205-9. PubMed ID: 1912111
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute tryptophan depletion in schizophrenic patients treated with clozapine.
    George TP; Potenza MN; Degen K; Sernyak MJ; Woods S; McDougle CJ
    Arch Gen Psychiatry; 2002 Mar; 59(3):291-2. PubMed ID: 11879174
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between residual symptomatology and auditory evoked potentials in schizophrenic outpatients.
    Hegerl U; Gaebel W; Ulrich G
    Pharmacopsychiatry; 1988 Nov; 21(6):329-30. PubMed ID: 2907638
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.
    Feifel D; Macdonald K; Nguyen A; Cobb P; Warlan H; Galangue B; Minassian A; Becker O; Cooper J; Perry W; Lefebvre M; Gonzales J; Hadley A
    Biol Psychiatry; 2010 Oct; 68(7):678-80. PubMed ID: 20615494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bimanol Polfa in treatment of post-neuroleptic abulic-apathic syndromes in schizophrenic patients].
    Bukowczyk A; Cymbala J; Wasik A
    Neurol Neurochir Psychiatr Pol; 1966 Dec; 16(12):1403-5. PubMed ID: 5973523
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cognition and driving in schizophrenic patients under treatment with risperidone vs. haloperidol].
    Dittert S; Soyka M; Winter C; Möller HJ
    Fortschr Neurol Psychiatr; 1999 Nov; Suppl 2():S70-3. PubMed ID: 10598340
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in cognition, attention and language in acute schizophrenia.
    Blum RA; Livingston PB; Shader RI
    Dis Nerv Syst; 1969 Jan; 30(1):31-6. PubMed ID: 5775757
    [No Abstract]   [Full Text] [Related]  

  • 13. Central serotonergic function in patients with predominantly negative symptoms of schizophrenia.
    Uhl I; Kulik A; Roser P; Theodoridou A; Wyss C; Norra C; Brüne M; Kawohl W; Juckel G
    Schizophr Res; 2018 Mar; 193():443-444. PubMed ID: 28641887
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful use of add-on minocycline for treatment of persistent negative symptoms in schizophrenia.
    Jhamnani K; Shivakumar V; Kalmady S; Rao NP; Venkatasubramanian G
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):E06-7. PubMed ID: 23487204
    [No Abstract]   [Full Text] [Related]  

  • 15. Seroquel and cognitive improvement in patients with schizophrenia.
    Stip E; Lussier I; Babai M; Fabian JL; Link C
    Biol Psychiatry; 1996 Sep; 40(5):434-5. PubMed ID: 8874852
    [No Abstract]   [Full Text] [Related]  

  • 16. Clozapine, cognition, and schizophrenia.
    Launer M
    Br J Psychiatry; 1993 Apr; 162():567-8. PubMed ID: 8481757
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of depot neuroleptics on driving performance in chronic schizophrenic patients.
    Wylie KR; Thompson DJ; Wildgust HJ
    J Neurol Neurosurg Psychiatry; 1993 Aug; 56(8):910-3. PubMed ID: 8102393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated eye movement score as a neurophysiological marker of schizophrenia.
    Miura K; Hashimoto R; Fujimoto M; Yamamori H; Yasuda Y; Ohi K; Umeda-Yano S; Fukunaga M; Iwase M; Takeda M
    Schizophr Res; 2014 Dec; 160(1-3):228-9. PubMed ID: 25458574
    [No Abstract]   [Full Text] [Related]  

  • 19. Paradoxical reaction to L-dopa in schizophrenic patients.
    Alpert M; Friedhoff AJ; Marcos LR; Diamond F
    Am J Psychiatry; 1978 Nov; 135(11):1329-32. PubMed ID: 707630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontal lobe tasks, antipsychotic medication, and schizophrenia syndromes.
    Himelhoch S; Taylor SF; Goldman RS; Tandon R
    Biol Psychiatry; 1996 Feb; 39(3):227-9. PubMed ID: 8837987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.